Phlebology The Journal of Venous Disease · 2010 · 117 citations · 11 references
MedicineSurgeryBiomedical OpticsMicrosurgeryVascular SurgeryAblation TherapyBiomedical Laser ApplicationsLaser SurgeryLaser-tissue InteractionAblative Laser SurgeryAblative Laser TherapyEndovenous Laser AblationLaser AblationLaser CoagulationLaser Energy AbsorptionLaser Surgery SystemsLaser Therapy Of Vascular Lesions
BACKGROUND: Endovenous laser ablation (EVLA) is an efficient method to treat insufficient great saphenous veins (GSV) with high occlusion rates. Most studies used 810, 940 or 980 nm diode lasers and a bare fibre. Moderate postoperative pain and bruising are frequent findings. Laser systems with higher wavelengths like 1470 nm with a higher absorption in water show less pain and bruising after the procedure. A newly-developed fibre (radial fibre, Biolitec) emits the laser energy radially around the tip directly into the venous wall contrary to the bare fibre.(9) The aim of this study was to demonstrate the outcome and side-effects after EVLA of GSV with a 1470 nm diode laser (Ceralas E, Biolitec) by using the radial fibre. METHODS: Non-randomized, prospective study including 50 unselected limbs of 50 patients with a duplex sonographically verified incompetent GSV. EVLA was performed with a 1470 nm diode laser (Ceralas E, Biolitec) and a radial fibre. In the same session all insufficient tributaries were treated by phlebectomy. Tumescent local anaesthesia with 0.05% lidocaine was applied perivenously. Laser treatment was carried out in a continuous mode with a power of 15 W. Compression stockings (30 mmHg) were applied for one month. Postinterventional checkups took place one, 10, 30 days and six months after the procedure. RESULTS: Three patients were lost to follow-up. The average linear endovenous energy density (LEED) was 90.8 J/cm vein (SD 35.3). At the six month follow-up all treated veins remained occluded and no new reflux in the treated segments occurred. No recurrent varicose veins had occurred so far. No severe complications such as deep venous thrombosis could be detected. In four patients at 30 days and three patients at six months local paresthesia occurred in the region of EVLA. Forty-four percent of patients did not have any pain after the treatment and 50% did not take any analgesic tablets at any time after the procedure. Postoperative ecchymoses in the track of the treated GSV was rare. In 80% of the limbs, no ecchymoses was observed after the treatment. CONCLUSION: EVLA of GSV with a radially emitting laser fibre by using a 1470 nm diode laser is a safe and efficient treatment option.
11
Thomas M. Proebstle, Hans‐Anton Lehr, A. Kargl et al. · Journal of Vascular Surgery · 2002 · 411 citations · Full text
Medicine, Surgery, Hemostasis +11
José I. Almeida, John A. Kaufman, Oliver Göckeritz et al. · Journal of Vascular and Interventional Radiology · 2009 · 287 citations